Medicare Enrolled

Dr. Sakib Qureshi, M.D.

Neurology · Atlanta, GA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
1110 W PEACHTREE ST NW STE 1100, Atlanta, GA 30309
4048922131
In practice since 2008 (18 years)
NPI: 1215105051 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Qureshi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Qureshi? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Qureshi

Dr. Sakib Qureshi is a neurology specialist in Atlanta, GA, with 18 years of NPI registration. Based on federal Medicare data, Dr. Qureshi performed 9,817 Medicare services across 397 unique beneficiaries.

Between the years covered by Open Payments, Dr. Qureshi received a total of $9,188 from 73 pharmaceutical and/or device companies across 478 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Qureshi is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice ▲ Top 11% volume in GA $9,188 industry payments

Medicare Practice Summary

Medicare Utilization ↗
9,817
Medicare services
Top 11% in GA for neurology
397
Unique beneficiaries
$9
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~545 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Botox injection, per unit
An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered.
9,300 $5 $12
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
264 $89 $214
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
132 $68 $153
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
74 $80 $208
Bilateral facial and neck nerve muscle paralysis injection
Injection of a chemical agent to paralyze muscles in the face and neck on both sides.
34 $122 $354
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
13 $8 $20
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$9,188
Total received (2018-2024)
Avg $1,313/year across 7 years
Top 27% in GA for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
73
Companies
478
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,175 (99.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$13 (0.1%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,952
2023
$2,199
2022
$2,065
2021
$1,082
2020
$571
2019
$1,254
2018
$65

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$561
ACADIA Pharmaceuticals Inc
$162
Inspire Medical Systems, Inc.
$120
Lundbeck LLC
$96
UCB, Inc.
$93
Teva Pharmaceuticals USA, Inc.
$87
PFIZER INC.
$79
TG Therapeutics, Inc.
$70
ARGENX US, INC.
$69
Medtronic, Inc.
$65
SK Life Science, Inc.
$62
Azurity Pharmaceuticals, Inc.
$53
Mannkind Corporation
$51
Eisai Inc.
$44
Biogen, Inc.
$39
Abbott Laboratories
$32
Amgen Inc.
$32
Novo Nordisk Inc
$31
Otsuka America Pharmaceutical, Inc.
$28
Alexion Pharmaceuticals, Inc.
$27
Avadel CNS Pharmaceuticals, LLC
$24
Ascendis Pharma Inc
$21
Xeris Pharmaceuticals, Inc.
$19
SCILEX PHARMACEUTICALS INC.
$19
Genentech USA, Inc.
$18
Novartis Pharmaceuticals Corporation
$17
Lilly USA, LLC
$16
GlaxoSmithKline, LLC.
$16
Top 3 companies account for 43.2% of 2024 payments
All-time payments by company (2018-2024) ›
ABBVIE INC.
$1,553
Amgen Inc.
$1,137
UCB, Inc.
$411
ACADIA Pharmaceuticals Inc
$363
Biogen, Inc.
$345
Allergan Inc.
$340
Teva Pharmaceuticals USA, Inc.
$310
Abbott Laboratories
$298
Lundbeck LLC
$279
AbbVie Inc.
$273
Kyowa Kirin, Inc.
$200
Lilly USA, LLC
$184
Novartis Pharmaceuticals Corporation
$158
Supernus Pharmaceuticals, Inc.
$156
IMPEL PHARMACEUTICALS INC.
$153
PFIZER INC.
$152
Genentech USA, Inc.
$126
Biohaven Pharmaceutical Holding Company Ltd.
$124
Novo Nordisk Inc
$121
Mannkind Corporation
$121
Inspire Medical Systems, Inc.
$120
Allergan, Inc.
$115
TG THERAPEUTICS, INC.
$114
MannKind Corporation
$92
GENZYME CORPORATION
$90
SK Life Science, Inc.
$87
UPSHER-SMITH LABORATORIES LLC
$85
Otsuka America Pharmaceutical, Inc.
$83
ARGENX US, INC.
$82
Amarin Pharma Inc.
$74
Horizon Therapeutics plc
$72
TG Therapeutics, Inc.
$70
Azurity Pharmaceuticals, Inc.
$69
Medtronic, Inc.
$65
Xeris Pharmaceuticals, Inc.
$65
Alnylam Pharmaceuticals Inc.
$63
Sunovion Pharmaceuticals Inc.
$62
GlaxoSmithKline, LLC.
$59
CSL Behring
$50
Merz Pharmaceuticals, LLC
$47
Eisai Inc.
$44
Grifols USA, LLC
$43
US WorldMeds, LLC
$43
Shire North American Group Inc
$41
JAZZ PHARMACEUTICALS INC.
$40
Dexcom, Inc.
$39
Avanir Pharmaceuticals, Inc.
$39
Harmony Biosciences LLC
$37
Corcept Therapeutics
$36
Bayer HealthCare Pharmaceuticals Inc.
$35
Celgene Corporation
$30
Greenwich Biosciences, Inc.
$29
Alexion Pharmaceuticals, Inc.
$27
Avadel CNS Pharmaceuticals, LLC
$24
Merck Sharp & Dohme LLC
$24
Bausch Health US, LLC
$22
Akcea Therapeutics, Inc.
$22
Ascendis Pharma Inc
$21
Avion Pharmaceuticals
$19
Amneal Pharmaceuticals LLC
$19
SCILEX PHARMACEUTICALS INC.
$19
IDORSIA PHARMACEUTICALS US INC
$16
Neurelis, Inc.
$16
MDD US Operations, LLC
$15
Zyla Life Sciences
$15
Adamas Pharmaceuticals, Inc.
$15
Exact Sciences Corporation
$14
ARBOR PHARMACEUTICALS, INC.
$14
Janssen Pharmaceuticals, Inc
$14
Acorda Therapeutics, Inc
$13
EMD Serono, Inc.
$13
AstraZeneca Pharmaceuticals LP
$11
Merck Sharp & Dohme Corporation
$11
Top 3 companies account for 33.8% of all-time payments
Associated products mentioned in payments ›
AFREZZA · AIMOVIG · AJOVY · AMYVID · APOKYN · APTIOM · AUBAGIO · AUSTEDO · Aimovig · Austedo XR · BELSOMRA · BOTOX · BOTOX THERAPEUTIC · BRIUMVI · Balcoltra · Briviact · COMIRNATY · Cologuard Collection Kit · Dexcom G6 Transmitter · ELYXYB - CELECOXIB · EMGALITY · EPIDIOLEX · EVENITY · Enbrel · Enspryng · Epidiolex · Evrysdi · FARXIGA · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre 2 · GILENYA · GOCOVRI · GVOKE HYPOPEN · GVOKE PFS · Gamunex-C · HORIZANT · Hizentra · Horizant · INBRIJA · INSPIRE · Infinity DBS Pulse Generators · JANUVIA · JARDIANCE · KESIMPTA · KRYSTEXXA · Kerendia · Korlym · LEQEMBI · LEQVIO · LUMRYZ · LYRICA · Leqembi · MIGRANAL · MINIMED 780G · MOUNJARO · Mavenclad · NATPARA (PARATHYROID HORMONE) · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Neupro · Nourianz · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONPATTRO · Otezla · Ozempic · POMPE - DISEASE · QULIPTA · QUVIVIQ · REXULTI · Repatha · Rybelsus · Rystiggo · SHINGRIX · SKYCLARYS · SOLIRIS · SPINRAZA · SPRIX · TEGSEDI · TOSYMRA · TROKENDI XR · TYSABRI · Trudhesa · UBRELVY · UNITHROID · UPLIZNA · VALTOCO · VRAYLAR · VYEPTI · VYVGART · VYVGART HYTRULO · Vascepa · WAKIX · Wakix · Wegovy · XCOPRI · Xadago · Xeomin · ZEMBRACE SYMTOUCH · ZEPOSIA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a neurology specialist in Atlanta?
Compare neurologists in the Atlanta area by procedure volume, costs, and industry payment transparency.
Browse neurologists nearby

Geographic Context

Neurologists within 10 mi
242
Per 100K population
22.6
County median income
$91,490
Nearest hospital
PIEDMONT HOSPITAL, INC
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Qureshi is a mixed practice specialist, with above-average Medicare volume (top 11% in GA), with low-engagement industry engagement, with 18 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Qureshi experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Qureshi performed 9,300 botox injection, per unit services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Qureshi receive payments from pharmaceutical companies?
Yes. Dr. Qureshi received a total of $9,188 from 73 companies across 478 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Qureshi's costs compare to other neurologists in Atlanta?
Dr. Qureshi's average Medicare payment per service is $9. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Qureshi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →